SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Description

International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical trial enrollment (CTE), as well as the financial impact, and potential outcomes of the intervention.

Study Start Date

January, 01 2018

Estimated Completion Date

December 2022

Interventions

  • Other: Clinical Trial Matching

Study ID

Massive Bio, Inc. -- SYNERGY-AI

Status

Recruiting

Trial ID

NCT03452774

Study Type

Observational [Patient Registry]

Trial Phase

N/A

Enrollment Quota

1500

Sponsor

Massive Bio, Inc.

Inclusion Criteria

  • Pts with solid and hematological malignancies
  • Pts cancer-related biomarkers (e.g. EGFR, ALK, TRK, ERBB2, ROS-1) determined by local laboratory, external vendor, or next generation sequencing platform
  • Decision to consider clinical trial pre-screening enrollment (CTE) by primary provider and/or patient

Exclusion Criteria

  • ECOG PS > 2
  • Abnormal organ function
  • Hospice enrollment

Gender

All

Ages

N/A

Accepts Healthy Volunteers

No

Study Locations and Contact Information (1)

Study Location Distance Name Phone Email
Massive Bio Inc - New York, New York 53.3 miles Kristin Johnston RN 844-627-7246 support@massbio.io

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.